Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 2873 entries
View as:

Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00113841 Org: User:
Start: 11/30/04 End: 08/31/09 Due: 08/31/10

Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01092728 Org: User:
Start: 03/31/11 End: 08/31/14 Due: 08/31/15

Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04487106 Org: User:
Start: 07/21/20 End: 01/25/24 Due: 01/25/25

Psychophysical Studies of Cancer Therapy Pain

Phase: N/A Priority: Normal
NCT ID: NCT00515060 Org: User:
Start: 01/23/01 End: 04/30/28 Due: 04/30/29

Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II

Phase: N/A Priority: Normal
NCT ID: NCT02942212 Org: User:
Start: 12/14/18 End: 12/14/18 Due: 12/14/19

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00828126 Org: User:
Start: 01/31/09 End: 03/31/12 Due: 03/31/13

Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00800566 Org: User:
Start: 11/30/08 End: 04/30/09 Due: 04/30/10

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

Phase: N/A Priority: Normal
NCT ID: NCT03868020 Org: User:
Start: 04/24/19 End: 03/22/24 Due: 03/22/25

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00756639 Org: User:
Start: 07/21/08 End: 12/30/25 Due: 12/30/26

Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A

Phase: N/A Priority: Normal
NCT ID: NCT00221039 Org: User:
Start: 04/02/04 End: 04/05/11 Due: 04/05/12

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02874885 Org: User:
Start: 09/05/13 End: 04/30/25 Due: 04/30/26

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

Phase: N/A Priority: Normal
NCT ID: NCT00555399 Org: User:
Start: 11/28/07 End: 01/24/20 Due: 01/24/21

Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)

Phase: N/A Priority: Normal
NCT ID: NCT00748774 Org: User:
Start: 05/31/08 End: 09/30/14 Due: 09/30/15

Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00514189 Org: User:
Start: 07/31/07 End: 12/31/09 Due: 12/31/10

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03452930 Org: User:
Start: 08/13/18 End: 06/05/24 Due: 06/05/25

Proton Beam Therapy for Chordoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00496119 Org: User:
Start: 09/18/06 End: 12/31/25 Due: 12/31/26

Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT05038592 Org: User:
Start: 03/04/22 End: 01/29/26 Due: 01/29/27

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00513357 Org: User:
Start: 06/30/06 End: 12/31/12 Due: 12/31/13

Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05045404 Org: User:
Start: 06/16/21 End: 02/02/23 Due: 02/02/24

Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT00067028 Org: User:
Start: 12/31/03 End: 06/30/13 Due: 06/30/14

Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging

Phase: N/A Priority: Normal
NCT ID: NCT00499382 Org: User:
Start: 09/30/04 End: 03/31/09 Due: 03/31/10

Precision Optical Guidance for Oral Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT05554133 Org: User:
Start: 06/15/23 End: 03/31/27 Due: 03/31/28

Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease

Phase: N/A Priority: Normal
NCT ID: NCT03050762 Org: User:
Start: 10/05/11 End: 10/31/27 Due: 10/31/28

Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients

Phase: N/A Priority: Normal
NCT ID: NCT00526110 Org: User:
Start: 08/31/04 End: 06/30/15 Due: 06/30/16

Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03067571 Org: User:
Start: 10/27/17 End: 11/21/22 Due: 11/21/23